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Abstract
OBJECTIVES: Extracorporeal circulation induces cellular and humoral inflammatory reactions, thus possibly leading to detrimental
secondary inflammatory responses. Previous data have demonstrated the bioactive potential of methane and confirmed its anti-
inflammatory effects in model experiments. Our goal was to investigate the in vivo consequences of exogenous methane administration
on extracorporeal circulation-induced inflammation.
METHODS: Two groups of anaesthetized Vietnamese minipigs (non-treated and methane treated, n = 5 each) were included. Standard
central cannulation was performed, and extracorporeal circulation was maintained for 120 min without cardiac arrest or ischaemia, fol-
lowed by an additional 120-min observation period with haemodynamic monitoring. In the methane-treated group, 2.5% v/v methane–
normoxic air mixture was added to the oxygenator sweep gas. Blood samples through the central venous line and tissue biopsies from the
heart, ileum and kidney were taken at the end point to determine the whole blood superoxide production (chemiluminometry) and the
activity of xanthine-oxidoreductase and myeloperoxidase, with substrate-specific reactions.
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RESULTS: Methane treatment resulted in significantly higher renal blood flow during the extracorporeal circulation period compared to
the non-treated group (63.9 ± 16.4 vs 29.0 ± 9.3 ml/min). Whole blood superoxide production (548 ± 179 vs 1283 ± 193 Relative Light Unit
(RLU)), ileal myeloperoxidase (2.23 ± 0.2 vs 3.26 ± 0.6 mU/(mg protein)) and cardiac (1.5 ± 0.6 vs 4.7 ± 2.5 pmol/min/mg), ileal (2.2 ± 0.6 vs
7.0 ± 3.4 pmol/min/mg) and renal (1.2 ± 0.8 vs 13.3 ± 8.0 pmol/min/mg) xanthine-oxidoreductase activity were significantly lower in the
treated group.
CONCLUSIONS: The addition of bioactive gases, such as methane, through the oxygenator of the extracorporeal circuit represents a novel
strategy to influence the inflammatory effects of extracorporeal perfusion in cardiac surgical procedures.
Keywords: Extracorporeal perfusion • Systemic inflammation • Methane • Reactive oxygen species
INTRODUCTION
Since the first successful open-heart surgery using cardiopulmon-
ary bypass (CPB) (by John Gibbon), on 6 May 1953, thousands of
procedures requiring CPB have been carried out each year
worldwide. Despite the safety of modern CPB circuits, extracor-
poreal circulation is still associated with some degree of post-
operative systemic inflammatory response.
The blood in contact with the foreign surface of the CPB circuit
causes an immediate inflammatory response similar to the septic
systemic inflammatory response syndrome in which humoral
and cellular factors play an essential role [1]. The contact activa-
tion leads to intrinsic pathway of the coagulation and further ac-
tivation of proinflammatory cascades, triggering a wide variety of
cellular systems, such as endothelial cells, leucocytes, thrombo-
cytes and mast cells [2], leading to cytokine release and increased
activity of proinflammatory enzymes, contributing to oxidative
and nitrosative stress. If these cascade activations are dysregu-
lated due to prolonged CPB time, significant tissue and organ
damage can occur in sensitive organs such as the kidneys and
intestines [3, 4]. Therefore, a search for novel therapeutic strat-
egies to reduce post-CPB inflammatory damage is an important
clinical and scientific research goal.
We have previously shown that methane (CH4) has a potent anti-
inflammatory effect both in vitro and in vivo [5]. The exact mechan-
ism is not yet fully understood, but previous studies have demon-
strated the efficacy of CH4 in reducing reactive oxygen species
production through a possible influence on mitochondrial function
[6]. The therapeutic value of bioactive gases such as CH4 includes
easy administration via inhalation, low chemical reactivity and good
intra- and extracellular diffusion capabilities. Thus, the aim of this
study was to investigate the effects of exogenous CH4 on CPB-
induced systemic inflammation. We aimed to explore the potential
clinical benefits of this gas in a clinically relevant porcine model
with anatomical and immunological similarities to humans [7].
MATERIALS AND METHODS
The experiments were performed in accordance with National
Institutes of Health guidelines on the handling and care of ex-
perimental animals and EU Directive 2010/63 for the protection
of animals used for scientific purposes. The Animal Welfare
Committee of the University of Szeged approved the study (ap-
proval number V/148/2013).
Animal and anaesthesia
Male outbred Vietnamese minipigs (n = 10; weighing 45 ± 8 kg)
were used. A mixture of ketamine (20 mg/kg; CP-Ketamin 10%;
Pordulab Pharma, Raamsdonksveer, Netherlands) and azaperone
(2 mg/kg; Stresnil; Elanco Animal Health, Vienna, Austria) was
intramuscularly administered for anaesthesia induction. After the
endotracheal intubation, mechanical ventilation was started with
a tidal volume of 10 ml/kg, and the respiratory rate was adjusted
to maintain the end-tidal pressure of carbon dioxide and partial
pressure of carbon dioxide in the 35–45 mmHg range.
Anaesthesia was maintained with a continuous infusion of propo-
fol (6 mg/kg/h intravenous (iv); Propofol 2% MCT/LCT; Fresenius
Kabi, Bad Homburg, Germany), midazolam (1.2 mg/kg/h;
Midazolam Torrex; Torrex Chiesi Pharma, Vienna, Austria) and
fentanyl (0.02 mg/kg/h; Fentanyl-Richter; Richter Gedeon,
Budapest, Hungary), whereas muscle relaxation was maintained
with pipecuronium (a single administration of 4-mg dose;
Arduan; Richter Gedeon, Budapest, Hungary).
Surgical preparation
The anaesthetized animals were placed in the supine position on a
heating pad to maintain the body temperature between 36C and
37C and received an infusion of Ringer’s lactate solution at a rate
of 10 ml/kg/h during the experiments. The left jugular vein was
cannulated for fluid and drug administration, and the left femoral
artery was cannulated to measure the mean arterial pressure
(MAP), heart rate (HR) and cardiac index (CI) by transpulmonary
thermodilution. After the median laparotomy, the renal artery was
dissected free, and a flow probe was placed around it (Transonic
Systems Inc., Ithaca, NY, USA) to measure the blood flow. The
wound cut in the abdominal wall was then temporarily closed with
clips. A urinary catheter was surgically placed in the bladder via the
femoral incision. The urine was collected and measured at the end
of the observation period to calculate the average hour diuresis.
A median sternotomy was performed, and the pericardium
was dissected. The aorta was dissected free and encircled with a
tape. After the administration of heparin (Heparibene; Teva,
Budapest, Hungary) (2000 IU iv) and ACT control (ACT >500 s),
purse-string sutures were placed in the ascending aorta and the
right atrial appendage, and standard cannulation was performed.
Because of the lack of aortic cross-clamping and the fragility of
the upper pulmonary vein, venting was not used, the heart was
left to beat and eject. Cardiotomy suction was not used because
the aorta or the cardiac chambers were not opened. After base-
line haemodynamic measurements, CPB was initiated, and respir-
ation was ceased. Further, the cessation of the respiration
achieved maximum peak blood and cellular CH4 concentration
in the CH4-treated animals. The Du Bois formula was employed
to calculate the body surface area for a non-invasive estimate of
CI, and 2.4 l/min/m2 CI was used for all the animals. After the in-
sertion of the central venous line and the PiCCO cannula in the
femoral artery, CI was directly measured with the PiCCO system
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(PULSION Medical Systems; Munich, Germany) via thermodilu-
tion, and the flow settings were adjusted accordingly. The meas-
ured and estimated CI values were nearly identical in all cases.
Oxygenator gas sweeps were adjusted to post-membrane arterial
blood gas samples.
Experimental protocol
The animals (n = 10) were randomly allocated into 2 experimental
groups (n = 5, each group). In both groups, CPB was maintained
for 120 min and adjusted throughout according to the CI calcu-
lated for the animals. The heart was not cross-clamped and not
arrested to rule out ischaemia–reperfusion and the accompany-
ing inflammatory activation. Left heart venting was not used.
After 120 min of CPB, flow was gradually decreased and ceased.
The cannulas were removed, and the cannulation points were
surgically closed.
The non-treated CPB group received a standard air–oxygen
gas mixture with 0.6 FiO2 at a 2 l/min flow to the oxygenator. In
the CH4-treated (CPB+Met) group, 2.5% v/v normoxic CH4 (Linde
Gas, Hungary) was added to the oxygenator gas sweep at a rate
of 1 l/min. FiO2 values were adjusted to the post-oxygenator
PaO2 values. The CH4 content of the blood was monitored using
near-infrared laser technique-based photoacoustic spectroscopy
[8] after 60-min CH4 treatment. This approach and the dosing
regimen were based on the results of previous studies and rele-
vant literature data [5, 9, 10]. Increasing the CH4 concentrations
up to 2.5% in normoxic artificial air does not influence the blood
gas chemistry and haemodynamics in mechanically ventilated
anaesthetized dogs or in rodents, but this approach reduces in-
flammatory activation [5]. In previous rodent experiments, 15-
min inhalation of a normoxic CH4–air mixture with a flow rate of
300 ml/min resulted in 6.6 ppm/mg tissue CH4 in the ileum and
1.5 ppm/ml CH4 in the caval vein [10]. The duration of CPB and
the post-CPB times did not differ between the groups.
The post-CPB haemodynamic stability (MAP > 60 mmHg) of
the animal was maintained by continuous iv volume replacement
(Ringer’s lactate solution) and by maintaining the systemic vascu-
lar resistance with perfusion of norepinephrine if necessary
(0.05–0.35 lg/kg/h; Arterenol; Sanofi-Aventis, Frankfurt am Main,
Germany).
After 120 min of post-CPB monitoring, blood samples were
taken to detect whole blood superoxide (SOX) production, and
ileum, kidney and heart tissue biopsies were taken to measure
myeloperoxidase (MPO) and xanthine-oxidoreductase (XOR) en-
zyme activity (Fig. 1).
Measurements
Haemodynamic measurements. The MAP, CO and the HR
were monitored, and the maximum left ventricular contractility
(dp/dtmax) was calculated with the PICCO Plus monitoring sys-
tem. Blood flow signals (T206 Animal Research Flowmeter;
Transonic Systems Inc., Ithaca, NY, USA) were registered with a
computerized data acquisition system (SPELL Haemosys;
Experimetria, Budapest, Hungary).
Measurement of blood CH4 content. A near-infrared laser
technique-based photoacoustic spectroscopy apparatus [8] was
employed to confirm the presence of exogenous CH4 in the
blood. The blood samples were taken from the aorta and jugular
vein (5 ml from each) and placed in a glass vial with 20-ml head-
space volume and closed to be airtight. The outlet of the vials
was connected to the spectroscope pump, headspace gas was
pumped into the chamber of the device at a rate of 10 ml/min
and the CH4 content of the air above the blood samples was
measured. The CH4 values were corrected for background levels
and expressed in parts per million (ppm).
Tissue harvesting and processing. Tissue samples were har-
vested immediately after the animals were sacrificed. A circular
1–2.5 cm-thick sample was excised from the apical left ventricle.
After saline rinsing, the sample was stored in liquid nitrogen for
further analysis. The small intestine tissue samples were harvested
from the terminal ileum and stored as described before.
Tissue biopsies kept on ice were homogenized in phosphate
buffer (pH 7.4) containing 50 mM Tris-HCl (Reanal, Budapest,
Hungary), 0.1 mM EDTA, 0.5 mM dithiothreitol, 1 mM phenylme-
thylsulfonyl fluoride, 10lg/ml soybean trypsin inhibitor and
10 lg/ml leupeptin (Sigma-Aldrich GmbH, Germany). The hom-
ogenate was centrifuged at 4C for 20 min at 24 000 g, and the
supernatant was loaded into centrifugal concentrator tubes
(Amicon Centricon-100; 100 000 MW cut-off ultrafilter). XOR ac-
tivity was determined in the ultrafiltered supernatant, while that
of MPO was measured on the pellet of the homogenate.
Tissue myeloperoxidase activity. MPO activity was meas-
ured on the pellet of the homogenate [11]. Briefly, the pellet was
resuspended in K3PO4 buffer (0.05 M; pH 6.0) containing 0.5%
hexa-1,6-bis-decyltriethylammonium bromide. After 3 repeated
freeze-thaw procedures, the material was centrifuged at 4C for
20 min at 24 000 g, and the supernatant was used for MPO
Figure 1: The scheme of the experimental protocol. CPB: cardiopulmonary bypass.
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determination. Next, 0.15 ml of 3,30,5,50-tetramethylbenzidine
(dissolved in DMSO; 1.6 mM) and 0.75 ml of hydrogen peroxide
(dissolved in K3PO4 buffer; 0.6 mM) were added to 0.1 ml of the
sample. The reaction led to the hydrogen peroxide-dependent
oxidation of tetramethylbenzidine, which was detected spectro-
photometrically at 450 nm (UV-1601 spectrophotometer;
Shimadzu, Kyoto, Japan). MPO activities were measured at 37C;
then, the reaction was halted after 5 min with the addition of
0.2 ml of H2SO4 (2 M). The data were expressed in terms of pro-
tein content.
Xanthine-oxidoreductase enzyme activity. XOR activity
was determined in the ultrafiltered, concentrated supernatant
with a fluorometric kinetic assay based on the conversion of
pterine to isoxanthopterine in the presence (total XOR) or ab-
sence (xanthine-oxidase activity) of the electron acceptor methy-
lene blue [12].
Whole blood superoxide production. The chemilumino-
metric method developed by Zimmermann et al. [13] was used
for the whole blood SOX production measurements. During the
measurements, 10ll of whole blood was added to 1 ml of Hank’s
solution (PAA Cell Culture, Westborough, MA, USA), and the mix-
ture was maintained at 37C until assay. The chemiluminometric
response was measured with a Lumat LB9507 luminometer
(Berthold, Wildbad, Germany) during a 30-min period after the
addition of 100 ll of lucigenin.
Statistical analysis
Differences in the tissue XOR activity between the CH4-treated
and non-treated CPB groups were the primary outcome
measures. The sample sizes were estimated with PS: Power and
Sample Size Calculation 3.1 software.
Data analysis was performed with a statistical software package
(SigmaStat for Windows; Jandel Scientific, Erkrath, Germany).
Time-dependent differences from the baseline for each group
were assessed with the Friedman test followed by the Dunn’s
method. Differences between groups were analysed using the
Mann–Whitney test. The median values and 25th and 75th per-
centiles are provided in the figures; P-values of <0.05 were con-
sidered statistically significant. All reported P-values are 2-sided
and have not been adjusted for multiple testing.
RESULTS
Changes in renal arterial blood flow and hour
diuresis
A significantly decreased renal artery flow was detected during
CPB and in the post-CPB period in both groups (P = 0.009 and
PMet = 0.004) compared to the baseline values. Nonetheless, CH4
addition through the oxygenator resulted in significantly higher
renal blood flow during the CPB period in contrast to the non-
treated group (P-values at 0, 60, 120, 180 and 240 min are 0.91,
0.038, 0.029, 0.063 and 0.003, respectively; Fig. 2A). The hour di-
uresis during the observation period was significantly higher
(P = 0.016) in the CH4-treated group than in the animals without
treatment (Fig. 2B).
Changes in blood CH4 level
The photoacoustic spectroscopy data showed a 1.4-ppm increase
in CH4 concentration in the aortic blood sample above the
Figure 2: Changes in renal artery blood flow (A) in the CPB (n = 5; black circle with continuous line) and CPB+Met (n = 5; empty diamond with solid line) groups. The
plots demonstrate the median values and the 25th (lower whisker) and 75th (upper whisker) percentiles; *P < 0.05 within groups versus baseline values [the Friedman
test (P < 0.001) followed by the Dunn’s method] and #P < 0.05 between groups (the Mann–Whitney test; P-values at 0, 60, 120, 180 and 240 min are 0.91, 0.038, 0.029,
0.063 and 0.003, respectively). Hour diuresis (B) in the CPB (empty box) and CPB+Met (grey box) groups. The plots demonstrate the median (horizontal line in the
box), the 25th and 75th percentiles and the range of data (whiskers). #P = 0.016 between the groups (the Mann–Whitney test). CPB: cardiopulmonary bypass.
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background CH4 level. The CH4 concentration, measured in the
samples from the jugular vein, was significantly lower (P < 0.001)
than in the aortic samples (Fig. 3).
Changes in myeloperoxidase activity
The rate of neutrophil accumulation in the intestinal, heart and
kidney tissue was determined by measuring MPO activity.
Intestinal MPO activity was significantly lower (P = 0.016) in the
CPB+Met group in contrast to the non-treated group (Fig. 4A).
The MPO level in the heart (P = 0.537) and kidney (P = 0.905) tis-
sue showed no differences between the 2 groups (Fig. 4B and C).
Changes in xanthine-oxidoreductase activity
In the non-treated group, 2 h after the CPB period, XOR activity
was present in all 3 tissues examined at a significantly higher rate
(the ileum: P = 0.008; the heart: P = 0.005; and the kidney:
P = 0.016) compared with the values of the group with exogenous
CH4 administration (Fig. 5A–C).
Changes in blood superoxide production
Whole blood SOX production was reduced by the CH4 adminis-
tration (P = 0.010) at the end of the experiment—120 min after
CPB—in contrast to the CPB group (Fig. 6).
Haemodynamic changes and norepinephrine
demand
We could not observe differences in CI, MAP, HR or dp/dtmax be-
tween the 2 groups. Although CI and HR remained unchanged in
both groups during the experiments compared to the baseline
values, the MAP (P < 0.001 each) was significantly decreased by
240 min of the experiment which was accompanied by the in-
crease in dp/dtmax (P = 0.002 and PMet = 0.008). Because of
technical reasons (the absence of pulse curve during CPB), only
the set flow values of CPB are shown at 60 and 120 min in
Table 1.
During the post-CPB period, norepinephrine was administered
to maintain a minimum of 60 mmHg MAP. We have found sig-
nificant difference between the inotropic demand of the 2 ex-
perimental groups. The CH4-treated group required significantly
less (P = 0.006) norepinephrine support compared to the non-
treated group (Fig. 7).
DISCUSSION
To date, many refinements have improved the use of CPB in car-
diac surgery. Biocompatible circuits, the advanced oxygenator
and pump design [14] with shorter perfusion times have made
postoperative patient recovery more successful than ever before.
Figure 3: CH4 content of the blood in the aorta (empty box) and the jugular
vein (grey box). The plots demonstrate the median (horizontal line in the box),
the 25th and 75th percentiles and the range of data (whiskers). #P < 0.001 be-
tween the CH4 content in the aorta and that in the jugular vein (the Mann–
Whitney test).
Figure 4: Changes in small intestinal (A), heart (B) and kidney (C) myeloperoxidase activity in the CPB (n = 5; empty box) and CPB+Met (n = 5; grey box) groups. The
plots demonstrate the median (horizontal line in the box), the 25th and 75th percentiles and the range of data (whiskers). #P < 0.05 between groups (the Mann–
Whitney test). CPB: cardiopulmonary bypass.
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Nevertheless, some degree of systemic inflammation with an
altered organ redox state still develops, and it is still not possible
to overcome the severe inflammatory responses completely.
Complications more often evolve after longer perfusion times or
longer extracorporeal membrane oxygenation treatments.
The blood contact to foreign surfaces immediately triggers
the intrinsic activation of the coagulation cascade, leading to the
broad activation of different proinflammatory cascades and the
activation of neutrophils. It has been shown that proinflamma-
tory factors and the resultant oxidative stress limit postoperative
recovery of the vital organs [15, 16].
There has been a great effort to minimize the systemic inflam-
matory response syndrome effect with the addition of corticoste-
roids, but a recent large-scale study showed no significant
consequence in terms of mortality and morbidity [17]. Promising
results have been seen with cytokine adsorption techniques in
severe sepsis, leading to the idea of intraoperative cardiac
surgical utilization, but other results have shown no reduction in
the proinflammatory effect [18].
During the last decade, interest has increased in the potential
positive effects of bioactive gases such as H2, NO, CO and H2S. In
this line, the anti-inflammatory effect of inhaled CH4 has also
been demonstrated in a mesenteric ischaemia–reperfusion
model [5]. The addition of 2.5% v/v CH4 to the inhaled air
reduced gut injury and improved mucosal microcirculation. The
exact mechanism is not yet defined, but ample data have dem-
onstrated that CH4 exerts significant effects on the mitochondrial
function and reactive oxygen species production [19], which can
contribute to the reduction in oxidative stress induced by inflam-
matory processes and hypoperfusion. The effect can also be
mediated with the reduction in SOX production via the modula-
tion of the activity of reactive oxygen species-producing enzymes
such as XOR.
Renal function is frequently affected by CPB; there is, therefore,
a constant search for kidney-protecting methods. In the present
study, we observed a significant decrease in the renal arterial
flow during and after CPB, and despite a decrease, the flow was
significantly higher in the CH4-treated group than without the
addition of CH4. The increase also had a functional effect, as the
hour diuresis remained in the low normal range in the CH4-
treated group as compared to the oliguria of the animals without
CH4 treatment.
According to Vogel et al. [20], SOX is capable of directly
increasing Ca2+ influx in the smooth muscle cells of renal afferent
arterioles, resulting in vasoconstriction, which may cause a
decreased renal blood flow. The establishment of CPB inevitably
leads to a certain degree of hypoperfusion and activation of
SOX-producing enzymes such as NADPH-oxidase and XOR [15].
The significance of the effect of CH4 on oxidative stress enzymes
is emphasized by the lower SOX level in the blood samples in the
CH4-treated group. Another important finding of our study is the
decreased XOR activity in the cardiac tissue after the addition of
CH4. During tissue ischaemia and reperfusion, XOR is a significant
source of SOX and a known contributor to oxidative stress.
Allopurinol, an XOR inhibitor, has a protective effect against
ischaemia–reperfusion injury in different organs, and this effect
was utilized in the University of Wisconsin organ storage solution,
the gold standard in kidney preservation [21]. In the present
study, CH4 inhalation significantly decreased renal XOR activity,
thus possibly exercising an effect on renal function like that of
Figure 5: Changes in small intestinal (A), heart (B) and kidney (C) xanthine-oxidoreductase activity in the CPB (n = 5; empty box) and CPB+Met (n = 5; grey box) groups.
The plots demonstrate the median (horizontal line in the box), the 25th and 75th percentiles and the range of data (whiskers). #P < 0.05 between groups (the Mann–
Whitney test). CPB: cardiopulmonary bypass.
Figure 6: Changes in whole blood superoxide production in the CPB (n = 5;
empty box) and CPB+Met (n = 5; grey box) groups. The plots demonstrate the
median (horizontal line in the box), the 25th and 75th percentiles and the range
of data (whiskers). #P = 0.010 between groups (the Mann–Whitney test). CPB:
cardiopulmonary bypass.
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allopurinol. Decreased XOR activity was also measured in the
heart and small intestine samples, pointing to a non-organ-
specific effect of CH4. According to arterial and venous data, ap-
proximately 66% of the added CH4 is distributed across the body.
As a nonpolar molecule, besides the transport with blood flow,
the diffusion through cell membranes can provide biologically
accessible CH4 molecules, even in less perfused areas
(dissolved in lipids, non-polar regions of proteins, etc.).
In addition, CH4 treatment also reduced MPO activity in the
small intestine, suggesting decreased leucocyte infiltration after
CPB. Interestingly, this effect was absent in the heart and kidney,
a finding which is consistent with the experimental findings
reported by Murphy et al. [22], who also noted the lack of neu-
trophil infiltration into the renal tissue 1.5 h after CPB in a similar,
relatively short-term, non-recovery set-up. We explain the tissue
difference with the barrier nature and more pronounced im-
mune function of the intestinal mucosa. Here, the baseline MPO
values fall within a range 2 magnitude higher compared to those
of the other tissues. On the other hand, as a shock organ, the
small intestine is more exposed to the effects of hypoxia, caused
by the altered circulation during and after CPB; therefore, inflam-
matory activation may also be present on a much larger scale
and in an earlier time frame.
It should be noted that inotropic demand was significantly
lower in CH4-treated animals. Norepinephrine can influence
renal perfusion; however, the doses that were administered in
this study should not cause impairment of the renal circulation
[23]. Moreover, Schaer et al. [24] reported that norepinephrine
treatment increased renal blood flow in dogs until the peak dose
of 1.6 mg/kg/min, while the largest dose used in the present study
was 0.35mg/kg/min. It should be added that the effect of CH4
treatment on renal flow was already observed 60 min after the
start of CPB, thus ruling out the possible effect of inotropic treat-
ment on this parameter.
Limitations
It is important to list the limitations of the study. Pigs have im-
mune responses and cardiac anatomical and functional similar-
ities comparable to humans [7], and in a comparative study,
involving 4 species (rat, guinea pig, swine and human), the activ-
ity of XOR in the pig heart was like the activity measured in
human cardiac tissue, whereas it was a magnitude higher in rat
heart. Response to allopurinol is also similar [25]. Nonetheless,
these animals were healthy, without any accompanying cardio-
vascular alterations, while humans undergoing CPB are usually in
a severely impaired cardiovascular condition prior to surgery. In
addition, technical limitations were also present in this model.
The CPB circuits used in cardiac operations have more complex
tubing and use multiple roller pump modules for venting, cardi-
otomy suction and cardioplegia delivery. In addition, cardiotomy
suction aspirates blood from the surgical site, which has already
been in contact with tissue factor; thus, significant cellular activa-
tion has already taken place. Moreover, as the model lacked car-
dioplegia or any cardiac arrest, ischaemia of the cardiac tissue
was not present, thus possibly influencing the effectiveness of the
Table 1: Changes in haemodynamics parameters
Baseline 60 min 120 min 180 min 240 min
Cardiac index
CPB 2.27 (1.99–2.74) 2.30 (2.05–2.80) 2.30 (2.05–2.80) 1.90 (1.72–2.18) 1.79 (1.62–2.22)
CPB+Met 2.64 (2.18–3.10) 2.70 (2.25–3.17) 2.70 (2.25–3.17) 1.94 (1.54–2.35) 1.79 (1.59–2.06)
Mean arterial pressure
CPB 98.10 (94.75–100.75) Not available Not available 68.45 (66.25–72.12) 62.95* (62.12–63.75)
CPB+Met 97.00 (92.00–107.94) Not available Not available 70.87 (66.75–75.00) 64.00* (59.25–68.75)
Heart rate
CPB 98.50 (84.62–108.87) Not available Not available 91.40 (81.12–94.87) 94.75 (89.37–97.50)
CPB+Met 90.50 (76.25–104.75) Not available Not available 92.50 (79.75–109.00) 103.14 (97.25–110.50)
Maximum left ventricular contractility (dp/dtmax)
CPB 378.00 (333.75–431.250) Not available Not available 621.50 (453.75–685.00) 709.00* (642.50–865.00)
CPB+Met 435.00 (392.50–477.50) Not available Not available 763.33 (694.16–795.00) 811.42* (700.00–897.50)
The cardiac index (l/min/m2), mean arterial pressure (MAP; mmHg), heart rate, (1/min) and maximum left ventricular contractility (dp/dtmax; mmHg/s). Values are
presented as median and interquartile range.
*P < 0.05 within group versus baseline values [the Friedman test (MAP: P < 0.001 each; dp/dtmax: P = 0.002 and PMet = 0.008) followed by the Dunn’s test].
Figure 7: Norepinephrine demand in the CPB (n = 5; empty box) and CPB+Met
(n = 5; grey box) groups. The plots demonstrate the median (horizontal line in
the box), the 25th and 75th percentiles and the range of data (whiskers).
#P = 0.006 between groups (the Mann–Whitney test). CPB: cardiopulmonary
bypass.
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treatment. However, we provided evidence that CH4 administra-
tion might improve the consequences of CPB even under such
circumstances.
CONCLUSION
These results suggest that CH4 treatment may be a promising ap-
proach in reducing the oxidative stress and accompanying in-
flammatory response induced by CPB through the systemic
modulation of XOR activity.
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